Race Oncology Limited announced that Professor Borje Andersson has given notice that he will resign as Race's Chief Medical Officer (CMO) to enable Race to recruit a new Australian-based CMO to drive the Company's Three Pillar strategy forward in a full-time capacity. Prof. Andersson will remain the Chair of Race's Clinical Advisory Board. Race has commenced the recruitment process for an Australian based CMO. Professor Andersson will transition out of the role over a three-month duration.